APA (7th ed.) Citation

Kramer, B., Polit, M., Rotter, N., & Aderhold, M. C. (2018). HIF-1α and mTOR: Possible novel strategies of targeted therapies in p16-positive and -negative HNSCC. Cancer genomics & proteomics, 15(3), .

Chicago Style (17th ed.) Citation

Kramer, Benedikt, Max Polit, Nicole Rotter, and Marc Christoph Aderhold. "HIF-1α and MTOR: Possible Novel Strategies of Targeted Therapies in P16-positive and -negative HNSCC." Cancer Genomics & Proteomics 15, no. 3 (2018).

MLA (9th ed.) Citation

Kramer, Benedikt, et al. "HIF-1α and MTOR: Possible Novel Strategies of Targeted Therapies in P16-positive and -negative HNSCC." Cancer Genomics & Proteomics, vol. 15, no. 3, 2018.